Abstract:Heparin is a naturally produced, heterogeneous compound consisting of variably sulfated and acetylated repeating disaccharide units. The structural complexity of heparin complicates efforts to assess the purity of the compound, especially when differentiating between similar glycosaminoglycans. Recently, heparin sodium contaminated with oversulfated chondroitin sulfate A (OSCS) has been associated with a rapid and acute onset of an anaphylactic reaction. In addition, naturally occurring dermatan sulfate (DS) was found to be present in these and other heparin samples as an impurity due to incomplete purification. The present study was undertaken to determine whether chemometric analysis of these NMR spectral data would be useful for discrimination between USP-grade samples of heparin sodium API and those deemed unacceptable based on their levels of DS, OSCS, or both. Several multivariate chemometric methods for clustering and classification were evaluated; specifically, principal components analysis (PCA), partial least squares discriminant analysis (PLS-DA), linear discriminant analysis (LDA), and the k-nearest-neighbor (kNN) method. Data dimension reduction and variable selection techniques, implemented to avoid over-fitting the training set data, markedly improved the performance of the classification models. Under optimal conditions, a perfect classification (100% success rate) was attained on external test sets for the Heparin vs OSCS model. The predictive rates for the Heparin vs DS, Heparin vs [DS+OSCS], and Heparin vs DS vs OSCS models were 89%, 93%, and 90%, respectively. In most cases, misclassifications can be ascribed to the similarity in NMR chemical shifts of heparin and DS. Among the chemometric methods evaluated in this study, we found that the LDA models were superior to the PLS-DA and kNN models for classification. Taken together, the present results demonstrate the utility of chemometric methods when applied in combination with (1)H NMR spectral analysis for evaluating the quality of heparin APIs.

Modernization of Enoxaparin Molecular Weight Determination Using Homogeneous Standards

Analysis of sulfates on low molecular weight heparin using mass spectrometry: structural characterization of enoxaparin

Fingerprinting Analyses of Low Molecular Weight Heparin with an Orthogonal MHC 2D LC-MS System

Comprehensive Chromatographic Profiling and Structural Analysis of Key Anticoagulant Components in Enoxaparin

The US regulatory and pharmacopeia response to the global heparin contamination crisis

Method to Detect Contaminants in Heparin Using Radical Depolymerization and Liquid Chromatography-Mass Spectrometry

SAX-HPLC and HSQC NMR Spectroscopy: Orthogonal Methods for Characterizing Heparin Batches Composition

Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches

Bottom-up low molecular weight heparin analysis using liquid chromatography-Fourier transform mass spectrometry for extensive characterization.

Chemobiocatalytic Synthesis of a Low-Molecular-Weight Heparin

Novel method for the determination of average molecular weight of natural polymers based on 2D DOSY NMR and chemometrics: Example of heparin

Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants

Analysis of heparinase derived LMWH products using a MHC 2D LC system linked to Q-TOF MS

Enzymatic access to the rare ΔUA (1→4) Glc 3, 6, N-sulfated heparin disaccharide, implications for heparin quality control

Heparin Stability by Determining Unsubstituted Amino Groups Using Hydrophilic Interaction Chromatography Mass Spectrometry

Characterization of Epimerization and Composition of Heparin and Dalteparin Using a UHPLC-ESI-MS/MS Method.

Structure and Activity of a New Low-Molecular-weight Heparin Produced by Enzymatic Ultrafiltration.

Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin

Quantification of heparin in complex matrices (including urine) using a mix-and-read fluorescence assay

Determination Of Biological Potency Of Heparin Using Online Solid Phase Extraction Coupled With Liquid Chromatography-Tandem Mass Spectrometry

Heavy Heparin: A Stable Isotope-Enriched, Chemoenzymatically-Synthesized, Poly-Component Drug.